false 0000816956 0000816956 2024-05-22 2024-05-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 22, 2024

 

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   001-39218   16-0977505
(State or other jurisdiction of
incorporation or organization)		   (Commission File Number)   (I.R.S. Employer
Identification No.)

 

11311 Concept Blvd
Largo, FL		   33773
(Address of principal executive offices)   (Zip code)

 

(727) 392-6464

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Rule 12(b) of the Act

 

Title of each class  Trading Symbol  Name of each exchange on which registered
Common Stock, $0.01 par value  CNMD  NYSE

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

At the Company’s Annual Meeting of Stockholders held on May 22, 2024, stockholders voted on three proposals and cast their votes as follows:

 

1.The following table sets forth the names of the eight persons elected at the Annual Meeting to serve as directors until the first annual meeting of stockholders following the end of the Company’s fiscal year ending December 31, 2024, and the number of votes cast for, against or withheld with respect to each person.

 

   Shares
Name  For  Withhold  Broker Non-Votes
David Bronson  26,957,962  1,243,603  1,191,876
Brian Concannon  26,993,282  1,208,283  1,191,876
LaVerne Council  27,159,969  1,041,596  1,191,876
Charles Farkas  27,218,074  983,491  1,191,876
Martha Goldberg Aronson  27,365,061  836,504  1,191,876
Curt. R. Hartman  26,177,581  2,019,802  1,196,058
Barbara Schwarzentraub  27,327,255  874,310  1,191,876
John L. Workman  27,287,635  913,930  1,191,876

 

2.The advisory vote on the resolution relating to compensation of our named executive officers passed based upon the following votes:

 

Shares
For  Against  Abstain  Broker Non-Votes
27,090,070  1,069,964  41,569  1,191,838

 

3.The appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2024 was ratified based on the following votes:

 

Shares
For  Against  Abstain  Broker Non-Votes
27,290,715  2,097,183  5,543  0

 

 

Item 8.01Other Events

 

CONMED Corporation announced its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024.

 

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 22, 2024 CONMED CORPORATION
  (Registrant)
   
   
  By: /s/ Todd W. Garner
  Name: Todd W. Garner
  Title: Executive Vice President, Finance and Chief Financial Officer

 

 

 

v3.24.1.1.u2
Cover
May 22, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 22, 2024
Entity File Number 001-39218
Entity Registrant Name CONMED CORPORATION
Entity Central Index Key 0000816956
Entity Tax Identification Number 16-0977505
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 11311 Concept Blvd
Entity Address, City or Town Largo
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33773
City Area Code 727
Local Phone Number 392-6464
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value
Trading Symbol CNMD
Security Exchange Name NYSE
Entity Emerging Growth Company false
CONMED (NYSE:CNMD)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more CONMED Charts.
CONMED (NYSE:CNMD)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more CONMED Charts.